Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10
Closed -$721 703
2024
Q4
$721 Hold
10
﹤0.01% 701
2024
Q3
$815 Buy
+10
New +$800 ﹤0.01% 676
2022
Q4
Sell
-198
Closed -$13K 785
2022
Q3
$13K Sell
198
-95
-32% -$6.58K 0.01% 511
2022
Q2
$20K Hold
293
0.02% 393
2022
Q1
$23K Buy
+293
New +$21.1K 0.02% 429
2019
Q2
Sell
-37
Closed -$2K 326
2019
Q1
$2K Buy
+37
New +$1.67K ﹤0.01% 389

Other funds holding HOLX

Riverview Trust Company's HOLX Position: Q1 2025 in Review

Riverview Trust Company sold out of Hologic (HOLX) in Q1 2025, closing a stake of 10 shares — an estimated $721 sold.

Riverview Trust Company first reported a position in HOLX in Q1 2019 and held it in 6 quarters. The position peaked at $23K in Q1 2022. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Riverview Trust Company reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 10 Hologic shares in Q1 2025, an estimated $721.
  • Riverview Trust Company first reported a position in Hologic in Q1 2019 and held it in 6 quarters.
  • Riverview Trust Company's Hologic position peaked at $23K in Q1 2022.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.